| [2] |
Tornio A，Backman JT.Cytochrome P450 in pharmacogenetics：an update[J].Adv Pharmacol，2018，83：3-32.
|
| [6] |
Waring RH.Cytochrome P450：genotype to phenotype[J].Xenobiotica，2020，50（1）：9-18.
|
| [9] |
Parvez MK，Rishi V.Herb-drug interactions and hepatotoxicity[J].Curr Drug Metab，2019，20（4）：275-282.
|
| [10] |
Yeung KS，Gubili J，Mao JJ.Herb-drug interactions in cancer care[J].Oncology （Williston Park），2018，32（10）：516-520.
|
| [1] |
Magliocco G，Thomas A，Desmeules J，et al.Phenotyping of human CYP450 enzymes by endobiotics：current knowledge and mthodological approaches[J].Clin Pharmacokinet，2019，58（11）：1373-1391.
|
| [3] |
Isvoran A，Louet M，Vladoiu DL，et al.Pharmacogenomics of the cytochrome P450 2C family：impacts of amino acid variations on drug metabolism[J].Drug Discov Today，2017，22（2）：366-376.
|
| [4] |
Louet M，Labbe CM，Fagnen C，et al.Insights into molecular mechanisms of drug metabolism dysfunction of human CYP2C9*30[J].PLoS One，2018，13（5）：e0197249.
|
| [5] |
Damkier P，Lassen D，Christensen MMH，et al.Interaction between warfarin and cannabis[J].Basic Clin Pharmacol Toxicol，2019，124（1）：28-31.
|
| [7] |
Zheng E，Sandhu N，Navarro V.Drug-induced liver injury secondary to herbal and dietary supplements[J].Clin Liver Dis，2020，24（1）：141-155.
|
| [8] |
Grewal P，Ahmad J.Severe liver injury due to herbal and dietary supplements and the role of liver transplantation[J].World J Gastroenterol，2019，25（46）：6704-6712.
|
| [11] |
Borse SP，Singh DP，Nivsarkar M.Understanding the relevance of herb-drug interaction studies with special focus on interplays：a prerequisite for integrative medicine[J].Porto Biomed J，2019，4（2）：e15.
|
| [12] |
Ma ZF，Zhang H，Teh SS，et al.Goji berries as a potential natural antioxidant medicine：an insight into their molecular mechanisms of action[J].Oxid Med Cell Longev，2019，2019：2437397.
|
| [13] |
Lam AY，Elmer GW，Mohutsky MA.Possible interaction between warfarin and Lycium barbarum L.[J].Ann Pharmacother，2001，35（10）：1199-1201.
|
| [14] |
Leung H，Hung A，Hui AC，et al.Warfarin overdose due to the possible effects of Lycium barbarum L.[J].Food Chem Toxicol，2008，46（5）：1860-1862.
|
| [15] |
Zhang J，Tian L，Xie B.Bleeding due to a probable interaction between warfarin and Gouqizi （Lycium barbarum L.）[J].Toxicol Rep，2015，2：1209-1212.
|
| [16] |
Liu R，Tam TW，Mao J，et al.In vitro activity of Lycium barbarum （Goji） against major human phase I metabolism enzymes[J].J Complement Integr Med，2016，13（3）：257-265.
|
| [17] |
Li G，Simmler C，Chen L，et al.Cytochrome P450 inhibition by three licorice species and fourteen licorice constituents[J].Eur J Pharm Sci，2017，109：182-190.
|
| [18] |
Li G，Huang K，Nikolic D，et al.High-throughput cytochrome P450 cocktail inhibition assay for assessing drug-drug and drug-botanical interactions[J].Drug Metab Dispos，2015，43（11）：1670-1678.
|
| [19] |
Kim SJ，Kim SJ，Hong M，et al.Investigation of selective inhibitory effects of glycyrol on human CYP 1A1 and 2C9[J].Xenobiotica，2016，46（10）：857-861.
|
| [20] |
Li A，Ma N，Zhao Z，et al.Glycyrrhetinic acid might increase the nephrotoxicity of bakuchiol by inhibiting cytochrome P450 isoenzymes[J].Peer J，2016，4：e2723.
|
| [21] |
Zhao K，Ding M，Cao H，et al.In-vitro metabolism of glycyrrhetinic acid by human and rat liver microsomes and its interactions with six CYP substrates[J].J Pharm Pharmacol，2012，64（10）：1445-1451.
|
| [22] |
Sukumaran NP，Amalraj A，Gopi S.Neuropharmacological and cognitive effects of Bacopa monnieri （L.） Wettst-a review on its mechanistic aspects[J].Complement Ther Med，2019，44：68-82.
|
| [23] |
Kar A，Pandit S，Mukherjee K，et al.Safety assessment of selected medicinal food plants used in ayurveda through CYP450 enzyme inhibition study[J].J Sci Food Agric，2017，97（1）：333-340.
|
| [24] |
Ramasamy S，Kiew LV，Chung LY.Inhibition of human cytochrome P450 enzymes by Bacopa monnieri standardized extract and constituents[J].Molecules，2014，19（2）：2588-2601.
|
| [25] |
Tan ML，Lim LE.The effects of Andrographis paniculata（Burm.f.） nees extract and diterpenoids on the CYP450 isoforms′ activities, a review of possible herb-drug interaction risks[J].Drug Chem Toxicol，2015，38（3）：241-253.
|
| [26] |
Pekthong D，Martin H，Abadie C，et al.Differential inhibition of rat and human hepatic cytochrome P450 by Andrographis paniculata extract and andrographolide[J].J Ethnopharmacol，2008，115（3）：432-440.
|
| [27] |
Pan Y，Abd-Rashid BA，Ismail Z，et al.In vitro determination of the effect of Andrographis paniculata extracts and andrographolide on human hepatic cytochrome P450 activities[J].J Nat Med，2011，65（3-4）：440-447.
|
| [28] |
Pan Y，Abd-Rashid BA，Ismail Z，et al.In vitro modulatory effects on three major human cytochrome P450 enzymes by multiple active constituents and extracts of Centella asiatica[J].J Ethnopharmacol，2010，130（2）：275-283.
|
| [29] |
Savai J，Varghese A，Pandita N，et al.In vitro assessment of CYP1A2 and 2C9 inhibition potential of Withania somnifera and Centella asiatica in human liver microsomes[J].Drug Metab Pers Ther，2015，30（2）：137-141.
|
| [38] |
Matthews MK, Jr.Association of Ginkgo biloba with intracerebral hemorrhage[J].Neurology，1998，50（6）：1933-1934.
|
| [42] |
Zadoyan G，Rokitta D，Klement S，et al.Effect of Ginkgo
|
|
biloba special extract EGb 761on human cytochrome P450 activity：a cocktail interaction study in healthy volunteers[J].Eur J Clin Pharmacol，2012，68（5）：553-560.
|
| [30] |
Wright KM，Magana AA，Laethem RM，et al.Centella asiatica water extract shows low potential for cytochrome P450-mediated drug interactions[J].Drug Metab Dispos，2020，48（10）：1053-1063.
|
| [31] |
Mohutsky MA，Anderson GD，Miller JW，et al.Ginkgo biloba：evaluation of CYP2C9 drug interactions in vitro and in vivo[J].Am J Ther，2006，13（1）：24-31.
|
| [32] |
Gaudineau C，Beckerman R，Welbourn S，et al.Inhibition of human P450 enzymes by multiple constituents of the Ginkgo biloba extract[J].Biochemical Biophys Res Commun，2004，318（4）：1072-1078.
|
| [33] |
Etheridge AS，Black SR，Patel PR，et al.An in vitro evaluation of cytochrome P450 inhibition and p-glycoprotein interaction with goldenseal，Ginkgo biloba，grape seed，milk thistle，and ginseng extracts and their constituents[J].Planta Med，2007，73（8）：731-741.
|
| [34] |
Zou L，Harkey MR，Henderson GL.Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity[J].Life Sci，2002，71（13）：1579-1589.
|
| [35] |
von Moltke LL，Weemhoff JL，Bedir E，et al.Inhibition of human cytochromes P450 by components of Ginkgo biloba[J].J Pharm Pharmacol，2004，56（8）：1039-1044.
|
| [36] |
He N，Edeki T.The inhibitory effects of herbal components on CYP2C9 and CYP3A4 catalytic activities in human liver microsomes[J].Am J Ther，2004，11（3）：206-212.
|
| [37] |
Numa AM，Abbott FS，Chang TK.Effect of Ginkgo biloba extract on oxidative metabolism of valproic acid in hepatic microsomes from donors with the CYP2C9*1/*1 genotype[J].Can J Physiol Pharmacol，2007，85（9）：848-855.
|
| [39] |
Jiang X，Williams KM，Liauw WS，et al.Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects[J].Br J Clin Pharmacol，2005，59（4）：425-432.
|
| [40] |
Engelsen J，Nielsen JD，Winther K.Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in stable, long-term warfarin treated outpatients.A randomised, double blind,placebo-crossover trial[J].Thromb Haemost，2002，87（6）：1075-1076.
|
| [41] |
Greenblatt DJ，von Moltke LL，Luo Y，et al.Ginkgo biloba does not alter clearance of flurbiprofen，a cytochrome P450-2C9 substrate[J].J Clin Pharmacol，2006，46（2）：214-221.
|
| [43] |
Uchida S，Yamada H，Li XD，et al.Effects of Ginkgo biloba extract on pharmacokinetics and pharmacodynamics of tolbutamide and midazolam in healthy volunteers[J].J Clin Pharmacol，2006，46（11）：1290-1298.
|
| [44] |
Xiao J，Chen D，Lin XX，et al.Screening of drug metabolizing enzymes for the ginsenoside compound K In vitro：An efficient anti-cancer substance originating from panax ginseng[J].PLoS One，2016，11（2）：e0147183.
|
| [45] |
Henderson GL，Harkey MR，Gershwin ME，et al.Effects of ginseng components on c-DNA-expressed cytochrome P450 enzyme catalytic activity [J].Life Sci，1999，65 （15）：209-214.
|
| [46] |
Seong SJ，Kang WY，Heo J-K，et al.A Comprehensive In Vivo and In Vitro Assessment of the Drug Interaction Potential of Red Ginseng[J].Clin Ther，2018，40（8）：1322-1337.
|
| [47] |
Kim MG，Kim Y，Jeon JY，et al.Effect of fermented red ginseng on cytochrome P450 and P-glycoprotein activity in healthy subjects, as evaluated using the cocktail approach[J].Br J Clin Pharmacol，2016，82（6）：1580-1590.
|
| [48] |
Kim DS，Kim Y，Jeon JY，et al.Effect of red ginseng on cytochrome P450 and p-glycoprotein activities in healthy volunteers[J].J Ginseng Res，2016，40（4）：375-381.
|
| [49] |
Du G，Song J，Du L，et al.Chemical and pharmacological research on the polyphenol acids isolated from Danshen：A review of salvianolic acids[J].Adv Pharmacol，2020，87：1-41.
|
| [50] |
Wang X，Cheung CM，Lee WY，et al.Major tanshinones of danshen （Salvia miltiorrhiza）exhibit different modes of inhibition on human CYP1A2，CYP2C9，CYP2E1 and CYP3A4 activities in vitro[J].Phytomedicine，2010，17（11）：868-875.
|
| [51] |
Zhou X，Wang Y，Hu T，et al.Enzyme kinetic and molecular docking studies for the inhibitions of miltirone on major human cytochrome P450 isozymes[J].Phytomedicine，2013，20（3-4）：367-374.
|
| [52] |
Qiu F，Zhang R，Sun J，et al.Inhibitory effects of seven components of danshen extract on catalytic activity of cytochrome P450 enzyme in human liver microsomes[J].Drug Metab Dispos，2008，36（7）：1308-1314.
|
| [53] |
Banihani SA.Ginger and testosterone[J].Biomolecules，2018，8（4）：119.
|
| [54] |
Kimura Y，Ito H，Hatano T.Effects of mace and nutmeg on human cytochrome P450 3A4 and 2C9 activity[J].Biol Pharm Bull，2010，33（12）：1977-1982.
|
| [55] |
Qiu JX，Zhou ZW，He ZX，et al.Estimation of the binding modes with important human cytochrome P450 enzymes，drug interaction potential，pharmacokinetics，and hepatotoxicity of ginger components using molecular docking，computational,and pharmacokinetic modeling studies[J].Drug Des Devel Ther，2015，9：841-866.
|
| [56] |
Kim HJ，Kim IS，Rehman SU，et al.Effects of 6-paradol, an unsaturated ketone from gingers, on cytochrome P450-mediated drug metabolism[J].Bioorg Med Chem Lett，2017，27（8）：1826-1830.
|
| [57] |
Li M，Chen PZ，Yue QX，et al.Pungent ginger components modulates human cytochrome P450 enzymes in vitro[J].Acta Pharmacol Sin，2013，34（9）：1237-1242.
|
| [58] |
Ansary J，Forbes -Hernandez TY，Gil E，et al.Potential health benefit of garlic based on human intervention studies：a brief overview[J].Antioxidants （Basel），2020，9（7）：619.
|
| [59] |
Foster BC，Foster MS，Vandenhoek S，et al.An in vitro evaluation of human cytochrome P450 3A4 and p-glycoprotein inhibition by garlic[J].J Pharm Pharm Sci，2001，4（2）：176-184.
|
| [60] |
Greenblatt DJ，Leigh-Pemberton RA，von Moltke LL.In vitro interactions of water-soluble garlic components with human cytochromes p450[J].J Nutr，2006，136（3 Suppl）：806S-809S.
|
| [61] |
Ho BE，Shen DD，McCune JS，et al.Effects of garlic on cytochromes P450 2C9- and 3A4-mediated drug metabolism in human hepatocytes[J].Sci Pharm，2010，78（3）：473-481.
|
| [62] |
Amadi CN，Mgbahurike AA.Selected food/herb-drug interactions：mechanisms and clinical Relevance[J].Am J Ther，2018，25（4）：e423-e433.
|
| [63] |
Byeon JY，Kim YH，Kim SH，et al.The influences of CYP2C9*1/*3 genotype on the pharmacokinetics of zolpidem[J].Arch Pharm Res，2018，41（9）：931-936.
|
